Schizophrenia and Nogo: Elevated mRNA in cortex, and high prevalence of a homozygous CAA insert

Molecular Brain Research

Volumn 107, Issue 2, 2002, Pages 183-189

  Novak, G ^a   Kim, D ^a   Seeman, P ^a,b   Tallerico, T ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

3 Untranslated region; Gene expression; Genetic susceptibility; Neurodevelopment; Nogo; Polymorphism; Schizophrenia

Indexed keywords

GENOMIC DNA; MESSENGER RNA; MYELIN ASSOCIATED GLYCOPROTEIN; PROTEIN NOGO; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; BRAIN CORTEX; CADAVER; CONTROLLED STUDY; DNA EXTRACTION; DNA LIBRARY; DNA POLYMORPHISM; FRONTAL CORTEX; GENE INSERTION; GENE OVEREXPRESSION; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NERVE ENDING; NERVE FIBER GROWTH; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; RNA ANALYSIS; SCHIZOPHRENIA;

3' UNTRANSLATED REGIONS; ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; DNA TRANSPOSABLE ELEMENTS; DNA, COMPLEMENTARY; FEMALE; FRONTAL LOBE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HOMOZYGOTE; HUMANS; MALE; MOLECULAR SEQUENCE DATA; MUTATION; MYELIN PROTEINS; POLYMORPHISM, GENETIC; RNA, MESSENGER; SCHIZOPHRENIA; UP-REGULATION;

EUKARYOTA; MARTES PENNANTI;

EID: 0037112273     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(02)00492-8     Document Type: Article

References (36)

1. Am. Psychiatr. Association . Diagnostic and Statistical Manual of Mental Disorders. 4 Edition. 1994;American Psychiatric Association, Washington, DC.
2. Bassett A.S., Hodgkinson K., Chow E.W., Correia S., Scutt L.E., Weksberg R. 22q11 deletion syndrome in adults with schizophrenia. Am. J. Med. Genet. 81:1998;328-337.
3. Benes F.M. Emerging principles of altered neural circuitry in schizophrenia. Brain Res. Brain Res. Rev. 31:2000;251-269.
4. Berrettini W.H. Are schizophrenic and bipolar disorders related? A review of family and molecular studies. Biol. Psychiatry. 48:2000;531-538.
5. Brittis P.A., Flanagan J.G. Nogo domains and a Nogo receptor: implications for axon regeneration. Neuron. 30:2001;11-14.
6. Buffo A., Zagrebelsky M., Huber A.B., Skerra A., Schwab M.E., Strata P., Rossi F. Application of neutralizing antibodies against NI-35/250 myelin-associated neurite growth inhibitory proteins to the adult rat cerebellum induces sprouting of uninjured purkinje cell axons. J. Neurosci. 20:2000;2275-2286.
7. Bunney W.E., Bunney B.G. Evidence for a compromised dorsolateral prefrontal cortical parallel circuit in schizophrenia. Brain Res. Brain Res. Rev. 31:2000;138-146.
8. Cantor-Graae E., Nordstrom L.G., McNeil T.F. Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden. Schizophr. Res. 48:2001;69-82.
9. Chen M.S., Huber A.B., van der Haar M.E., Frank M., Schnell L., Spillmann A.A., Christ F., Schwab M.E. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature. 403:2000;434-439.
10. Conne B., Stutz A., Vassalli J.D. The 3′ untranslated region of messenger RNA: a molecular 'hotspot' for pathology? Nat. Med. 6:2000;637-641.
11. Coon H., Myles-Worsley M., Tiobech J., Hoff M., Rosenthal J., Bennett P., Reimherr F., Wender P., Dale P., Polloi A., Byerley W. Evidence for a chromosome 2p13-14 schizophrenia susceptibility locus in families from Palau, Micronesia. Mol. Psychiatry. 3:1998;521-527.
12. Diatchenko L., Lau Y.F., Campbell A.P., Chenchik A., Moqadam F., Huang B., Lukyanov S., Lukyanov K., Gurskaya N., Sverdlov E.D., Siebert P.D. Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc. Natl. Acad. Sci. USA. 93:1996;6025-6030.
13. Fournier A.E., GrandPre T., Strittmatter S.M. Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature. 409:2001;341-346.
14. Goldman-Rakic P.S., Selemon L.D. Functional and anatomical aspects of prefrontal pathology in schizophrenia. Schizophr. Bull. 23:1997;437-458.
15. GrandPre T., Nakamura F., Vartanian T., Strittmatter S.M. Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature. 403:2000;439-444.
16. Gray N.K., Wickens M. Control of translation initiation in animals. Annu. Rev. Cell. Dev. Biol. 14:1998;399-458.
17. Haberhausen G., Pinsl J., Kuhn C.C., Markert-Hahn C. Comparative study of different standardization concepts in quantitative competitive reverse transcription-PCR assays. J. Clin. Microbiol. 36:1998;628-633.
18. Huber A.B., Schwab M.E. Nogo-A, a potent inhibitor of neurite outgrowth and regeneration. Biol. Chem. 381:2000;407-419.
19. Huber A.B., Weinmann O., Brosamle C., Oertle T., Schwab M.E. Patterns of nogo mRNA and protein expression in the developing and adult rat and after CNS lesions. J. Neurosci. 22:2002;3553-3567.
20. Jansen R.P. mRNA localization: message on the move. Nat. Rev. Mol. Cell. Biol. 2:2001;247-256.
21. Josephson A., Widenfalk J., Widmer H.W., Olson L., Spenger C. NOGO mRNA expression in adult and fetal human and rat nervous tissue and in weight drop injury. Exp. Neurol. 169:2001;319-328.
22. Karayiorgou M., Morris M.A., Morrow B., Shprintzen R.J., Goldberg R., Borrow J., Gos A., Nestadt G., Wolyniec P.S., Lasseter V.K., et al. Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc. Natl. Acad. Sci. USA. 92:1995;7612-7616.
23. Kiebler M.A., DesGroseillers L. Molecular insights into mRNA transport and local translation in the mammalian nervous system. Neuron. 25:2000;19-28.
24. Maier W., Lichtermann D., Minges J., Hallmayer J., Heun R., Benkert O., Levinson D.F. Continuity and discontinuity of affective disorders and schizophrenia. Results of a controlled family study. Arch. Gen. Psychiatry. 50:1993;871-883.
25. Mitchell P., Tollervey D. mRNA turnover. Curr. Opin. Cell Biol. 13:2001;320-325.
26. Mohr E. Subcellular RNA compartmentalization. Prog. Neurobiol. 57:1999;507-525.
27. Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M., Miyajima N., Tanaka A., Kotani H., Nomura N., Ohara O. Prediction of the coding sequences of unidentified human genes. XII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res. 5:1998;355-364.
28. Pesole G., Liuni S., Grillo G., Licciulli F., Mignone F., Gissi C., Saccone C. UTRdb and UTRsite: specialized databases of sequences and functional elements of 5′ and 3′ untranslated regions of eukaryotic mRNAs. Update 2002. Nucleic Acids Res. 30:2002;335-340.
29. Prinjha R., Moore S.E., Vinson M., Blake S., Morrow R., Christie G., Michalovich D., Simmons D.L., Walsh F.S. Inhibitor of neurite outgrowth in humans. Nature. 403:2000;383-384.
30. Shaw S.H., Kelly M., Smith A.B., Shields G., Hopkins P.J., Loftus J., Laval S.H., Vita A., De Hert M., Cardon L.R., Crow T.J., Sherrington R., DeLisi L.E. A genome-wide search for schizophrenia susceptibility genes. Am. J. Med. Genet. 81:1998;364-376.
31. Skaper S.D., Moore S.E., Walsh F.S. Cell signalling cascades regulating neuronal growth-promoting and inhibitory cues. Prog. Neurobiol. 65:2001;593-608.
32. Torrey E.F., Webster M., Knable M., Johnston N., Yolken R.H. The Stanley Foundation Brain Collection and Neuropathology Consortium. Schizophr. Res. 44:2000;151-155.
33. Torrey E.F., Yolken R.H. Familial and genetic mechanisms in schizophrenia. Brain Res. Brain Res. Rev. 31:2000;113-117.
34. Waterwort D.M., Bassett A.S., Brzustowicz L.M. Recent advances in the genetics of schizophrenia. Cell. Mol. Life Sci. 59:2002;331-348.
35. Yang J., Yu L., Bi A.D., Zhao S.Y. Assignment of the human reticulon 4 gene (RTN4) to chromosome 2p14→2p13 by radiation hybrid mapping. Cytogenet. Cell. Genet. 88:2000;101-102.
36. Zagrebelsky M., Buffo A., Skerra A., Schwab M.E., Strata P., Rossi F. Retrograde regulation of growth-associated gene expression in adult rat Purkinje cells by myelin-associated neurite growth inhibitory proteins. J. Neurosci. 18:1998;7912-7929.